ProMIS Neurosciences
PMN
14 hedge funds and large institutions have $5.61M invested in ProMIS Neurosciences in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
675% more capital invested
Capital invested by funds: $724K → $5.61M (+$4.89M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
8% more funds holding
Funds holding: 13 → 14 (+1)
0.52% more ownership
Funds ownership: 0.09% → 0.61% (+0.52%)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.77M |
| 2 |
ABG
Ally Bridge Group
New York
|
+$1.38M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$691K |
| 4 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$25.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$30.8K |
| 2 |
JP Morgan Chase
New York
|
-$11.7K |
| 3 |
Morgan Stanley
New York
|
-$7.01K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4.62K |
| 5 |
CAM
Claret Asset Management
Montreal,
Quebec, Canada
|
-$3.9K |
PMN Hedge Fund Activity: Q3 2023 in Review
14 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q3 2023, worth a combined $5.61M — up 675% from $724K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PMN positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 5 trimmed.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $4.77M. The largest seller was Bank of America, cutting an estimated $30.8K.
- 14 institutional investors held ProMIS Neurosciences (PMN) as of Q3 2023, up from 13 in Q2 2023.
- Funds reported $5.61M of ProMIS Neurosciences stock for Q3 2023, up 675% quarter-over-quarter.
- 3 funds opened new ProMIS Neurosciences positions in Q3 2023 and 2 closed out, a net change of +1 holder.
- The largest ProMIS Neurosciences buyer in Q3 2023 was Sphera Funds Management, an estimated $4.77M added.
- The largest ProMIS Neurosciences seller in Q3 2023 was Bank of America, an estimated $30.8K sold.
Based on aggregated 13F filings for Q3 2023.